3.0.0 2129 2024-08-02T20:09:58Z 2024-08-02T20:09:58Z Senate S S 2023-06-22 118 ssfi00 Finance Committee Senate Standing Referred to 2023-06-22T16:40:30Z 2023-06-22 ssfi00 Finance Committee Senate Read twice and referred to the Committee on Finance. IntroReferral 2023-06-22 Introduced in Senate IntroReferral 10000 9 Library of Congress L000575 Sen. Lankford, James [R-OK] James Lankford R OK N M000639 Sen. Menendez, Robert [D-NJ] Robert Menendez D NJ 2023-06-22 True C001056 Sen. Cornyn, John [R-TX] John Cornyn R TX 2023-07-11 False P000603 Sen. Paul, Rand [R-KY] Rand Paul R KY 2023-07-11 False H001076 Sen. Hassan, Margaret Wood [D-NH] Maggie Hassan D NH 2023-07-12 False B001267 Sen. Bennet, Michael F. [D-CO] Michael Bennet D CO 2023-07-27 False Health Health 2023-07-19T16:30:27Z 00 2023-06-22 Introduced in Senate 2024-08-02T20:05:29Z Ensuring Access to Lower-Cost Medicines for Seniors Act

This bill requires prescription drug plans under the Medicare prescription drug benefit to include generic drugs and biosimilars on their formularies.

Specifically, the bill requires plans that use formularies to include generic drugs and biosimilars on the formularies and without any requirements (e.g., prior authorization requirements) that are more restrictive as compared to those for brand-name drugs and biologics. Plans that use cost-sharing tiers must also have specific tiers for generic drugs and biosimilars, in accordance with certain limitations.

]]> Ensuring Access to Lower-Cost Medicines for Seniors Act Display Title 45 Ensuring Access to Lower-Cost Medicines for Seniors Act 2024-07-24T15:21:32Z Short Title(s) as Introduced 101 Ensuring Access to Lower-Cost Medicines for Seniors Act 2024-05-24T13:38:37Z Introduced in Senate IS Official Title as Introduced 6 A bill to amend title XVIII of the Social Security Act to require PDP sponsors of a prescription drug plan and Medicare Advantage organizations offering an MA-PD plan under part D of the Medicare program that use a formulary to include certain drugs and biosimilar biological products on such formulary, and for other purposes. 2023-07-18T01:28:55Z Introduced in Senate IS Introduced in Senate 2023-06-22T04:00:00Z https://www.govinfo.gov/content/pkg/BILLS-118s2129is/xml/BILLS-118s2129is.xml 2023-06-22 Read twice and referred to the Committee on Finance. text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. Congressional Research Service, Library of Congress This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.